“Stat” Medication Administration Predicts Hospital Discharge

“Stat” Medication Administration Predicts Hospital Discharge Objective This study describes the use of “stat” medications for inpatients in a large state psychiatric hospital system, and examines the relationship between receipt of a “stat” for agitation and subsequent hospital discharge. Methods Use of “stat” medications in 2005 was retrospectively determined using a database that contains diagnosis and prescription information from 17 state-run adult civil facilities. A logistic regression model explored the relationship between receipt of a “stat” order for intramuscular preparations of either antipsychotics or lorazepam within the first 30 days of hospitalization and likelihood of hospital discharge by 6 months. Results Among 7,202 patients who received antipsychotic medication in 2005, 3,240 (45%) also received a “stat” psychotropic medication during that year. Among 40,651 stat orders, 19,142 (47%) were for intramuscular antipsychotics or lorazepam presumably given for the treatment of agitation. Among 1,673 patients admitted in the first 6 months of 2005, 415 (25%) received at least one such “agitation stat.” The percent discharged at six months among “agitation stat” receivers was 39%, compared to 69% among those who did not receive an “agitation stat” (chi-square = 115, df = 1, P < .001). Regression analysis showed that receiving an “agitation stat” in the first 30 days of hospitalization was associated with a 37% lower likelihood of being discharged by 6 months after admission (odds ratio .63, 95% CI: .46–.86). Conclusions “Stat” medications are commonly used. The use of “agitation stat” medications can be used as a proxy for clinical stability and may prove to be a useful outcome measure for future pharmacoepidemiologic studies of comparative medication effectiveness. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychiatric Quarterly Springer Journals

“Stat” Medication Administration Predicts Hospital Discharge

Loading next page...
 
/lp/springer_journal/stat-medication-administration-predicts-hospital-discharge-KkyQVBfuPO
Publisher
Springer US
Copyright
Copyright © 2009 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Psychiatry; Public Health; Sociology, general
ISSN
0033-2720
eISSN
1573-6709
D.O.I.
10.1007/s11126-009-9097-3
Publisher site
See Article on Publisher Site

Abstract

Objective This study describes the use of “stat” medications for inpatients in a large state psychiatric hospital system, and examines the relationship between receipt of a “stat” for agitation and subsequent hospital discharge. Methods Use of “stat” medications in 2005 was retrospectively determined using a database that contains diagnosis and prescription information from 17 state-run adult civil facilities. A logistic regression model explored the relationship between receipt of a “stat” order for intramuscular preparations of either antipsychotics or lorazepam within the first 30 days of hospitalization and likelihood of hospital discharge by 6 months. Results Among 7,202 patients who received antipsychotic medication in 2005, 3,240 (45%) also received a “stat” psychotropic medication during that year. Among 40,651 stat orders, 19,142 (47%) were for intramuscular antipsychotics or lorazepam presumably given for the treatment of agitation. Among 1,673 patients admitted in the first 6 months of 2005, 415 (25%) received at least one such “agitation stat.” The percent discharged at six months among “agitation stat” receivers was 39%, compared to 69% among those who did not receive an “agitation stat” (chi-square = 115, df = 1, P < .001). Regression analysis showed that receiving an “agitation stat” in the first 30 days of hospitalization was associated with a 37% lower likelihood of being discharged by 6 months after admission (odds ratio .63, 95% CI: .46–.86). Conclusions “Stat” medications are commonly used. The use of “agitation stat” medications can be used as a proxy for clinical stability and may prove to be a useful outcome measure for future pharmacoepidemiologic studies of comparative medication effectiveness.

Journal

Psychiatric QuarterlySpringer Journals

Published: Mar 14, 2009

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off